Pfizer (PFE) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.72 -1.44%
EPS Growth %: -12.8%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -12.8%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $0.53, $0.01 better than the analyst estimate of $0.52. Revenue for the quarter came in at $14.05 billion versus the consensus estimate of $13.57 billion.
Guidance:
The Company sees FY16 EPS of $2.20 - $2.30 and revenue of $49 - $51 billion. The Street is looking for EPS of $2.36 and revenue of $52.5 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
